|
GTX47810
|
GeneTex International Corporation
|
E2F2, Rabbit Polyclonal Antibody
|
Human, Mouse, Rat
|
ICC/IF, WB
|
|
|
GTX78241
|
GeneTex International Corporation
|
p53 [BP53-12] (FITC), Mouse Monoclonal Antibody
|
Human, Primate
|
ICC/IF, IHC
|
|
|
GTX80083
|
GeneTex International Corporation
|
TCR alpha + TCR beta [IP26] (FITC), Mouse Monoclonal Antibody
|
Human
|
FACS
|
|
|
GTX80131
|
GeneTex International Corporation
|
CD40 [HI40a] (FITC), Mouse Monoclonal Antibody
|
Human
|
FACS
|
|
|
C326-10
|
Dojindo EU GmbH
|
Calcein-AM [CAS 148504-34-1]
|
|
|
|
|
C375-10
|
Dojindo EU GmbH
|
CFSE [CAS 150347-59-4]
|
|
|
|
|
C396-10
|
Dojindo EU GmbH
|
Calcein-AM solution [CAS 148504-34-1(Calcein-AM)]
|
|
|
|
|
F209-10
|
Dojindo EU GmbH
|
FDA [CAS 596-09-8]
|
|
|
|
|
AR1176-10ml
|
Boster Biological Technology
|
DAPI [4',6-Diamidino-2-Phenylindole, Dihydrochloride] for nucleic acid staining
|
|
|
|
|
AR1176-50ml
|
Boster Biological Technology
|
DAPI [4',6-Diamidino-2-Phenylindole, Dihydrochloride] for nucleic acid staining
|
|
|
|
|
HY-130851-10mg
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130851-100mg
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130851-25mg
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130851-5mg
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130851-50mg
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130851-1mL
|
MedChemexpress LLC
|
HS-27 [CAS 1562024-11-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
